Pharmaceutical Drug Pricing and President Trump's Most-Favored-Nation Executive Order

The article discusses how the U.S. has been overpaying for pharmaceuticals due to lack of negotiation, leading to high drug prices compared to other countries. President Trump's Most-Favored-Nation Executive Order aims to peg drug prices paid by Medicare and Medicaid to the lowest amount paid by comparable foreign countries to stop the 'free ride' enjoyed by other nations.